Thymic carcinoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Marjan Khan (talk | contribs) No edit summary |
Marjan Khan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG | {{CMG}} ; {{Marjan}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 21:57, 25 July 2019
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma diagnostic study of choice |
|
Risk calculators and risk factors for Thymic carcinoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Marjan Khan M.B.B.S.[2]
Overview
The diagnostic study of choice for thymic carcinoma is tissue biopsy.
Diagnostic study of choice
The diagnostic study of choice for thymic carcinoma is tissue biopsy.[1]
References
- ↑ Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y; et al. (2019). "Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report". Asian J Endosc Surg. doi:10.1111/ases.12688. PMID 30714349.